The potential for better brain cooling
In a clinical trial with patients undergoing cardiac surgery, NeuroSave therapy demonstrated brain cooling that was:
Cooling the brain by 3°C in less than 15 minutes
Keeping the brain at least 3°C below core body temperature
Decreasing the brain temperature by 3.5 - 7.5°C
Our goal is to rapidly deliver the benefits of therapeutic hypothermia to the brain while protecting the body from the negative effects of cooling.
In a clinical trial, NeuroSave cooled the brain more than 10 times faster than non-surgical technology used in hospitals today.
NeuroSave is designed to cool primarily the brain, potentially reducing the risks associated with body cooling.
In a clinical trial, NeuroSave cooled the brain by more than 3.5°C.
NeuroSave employs a non-surgical approach with techniques and equipment familiar to physicians, nurses and paramedics.
The core NeuroSave design is versatile and small enough to be used inside and outside the hospital.